U.S. market Closed. Opens in 1 day 16 minutes

ABUS | Arbutus Biopharma Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
Revenue18.14M39.02M10.99M6.91M6.01M5.90M10.70M1.50M24.87M15.00M15.46M14.18M16.30M21.35M13.78M9.64M15.92M13.60M13.29M12.17M2.73M5.07M3.46M1.77M1.14M1.23M
Cost of Revenue73.70M1.43M1.75M47.48M57.60M57.90M62.70M61.30M51.51M38.70M21.46M18.13M19.49M22.13M16.97M13.25MN/A6.19MN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-55.56M37.59M9.23M-40.57M-51.59M-52.00M-52.00M-59.80M-26.63M-23.70M-5.99M-3.94M-3.19M-779.12K-3.19M-3.61M15.92M7.42M13.29M12.17M2.73M5.07M3.46M1.77M1.14M1.23M
Operating Expenses96.24M102.24M82.64M64.18M77.36M76.10M80.80M101.80M78.53M47.90M27.62M-19.49M7.14M11.73M5.88M4.73M13.28M9.10M14.38M35.55M37.38M32.79M19.87M10.97M9.31M9.98M
Selling, General & Admin22.48M17.83M17.14M14.72M17.73M16.00M16.10M39.40M26.44M8.70M5.55M26.89M6.18M4.78M3.97M3.62M4.44M3.85M3.78M7.76M6.78M5.52M3.10M2.25M1.57M1.33M
Research & Development73.70M84.41M65.50M47.48M57.60M57.90M62.70M61.30M51.51M38.70M21.46M18.13MN/A22.13TN/AN/A8.43M4.53M8.76M22.32M23.71M21.61M12.85M8.72M7.75M8.65M
Other Operating ExpensesN/A2.23M1.87M1.98M2.03M7.30M2.20M2.50M-770.00K-5.80MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-78.10M-65.46M-73.52M-57.81M-144.07M-89.80M-110.90M-491.60M-102.32M-33.00M-12.15M-12.99M-10.32M-12.51M-9.07M-10.95M2.64M-1.68M-5.96M-27.63M-34.65M-27.72M-16.41M-9.20M-8.17M-8.75M
Other Expenses / Income5.25M444.00K-2.73M-5.94M-22.48M28.44M2.20M2.47M25.02M-5.40M-1.91M42.56M574.19K-5.65M-466.28K-769.07K-5.22M19.76M-6.49M-4.03MN/AN/A455.26KN/AN/AN/A
Before Tax Income-72.85M-65.01M-76.25M-63.74M-166.38M-61.40M-108.70M-489.10M-77.31M-38.70M-14.06M29.95M-9.85M-12.52M-9.48M-11.72M-2.58M18.08M-7.67M-29.80MN/AN/A-15.96MN/AN/AN/A
Income Tax ExpensesN/A4.44M1.10M1.47M-12.66M-4.30M-24.30M-105.00M-16.18M100.00K1.91M3.72M-590.69K-99.82K259.76K3.38M0-2.31K388.32K8.95M-483.80K-852.14K-2.33M000
Net Income-72.85M-69.46M-77.35M-65.21M-153.72M-57.10M-84.40M-384.10M-61.12M-38.80M-14.06M29.95M-9.73M-12.41M-9.33M-11.72M-2.58M18.08M-8.06M-28.05M-34.08M-26.79M-14.02M-9.20M-8.17M-8.75M
Interest Expenses459.00K1.73M2.86M4.01M2.11M200.00K261.00KN/AN/AN/AN/A47.00K76.91KN/AN/AN/AN/A1.61MN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding165.96M150.94M106.24M75.84M57.09M55.30M54.69M53.05M45.45M21.58M15.29M13.73M11.32M10.33M10.33M8.12M4.77M3.86M7.71M7.70M7.13M6.57M5.07M4.93M2.82M2.16M
Diluted Shares Outstanding165.96M150.94M106.24M75.84M57.09M55.30M54.72M53.05M45.46M22.44M15.30M14.32M11.32M10.33M10.33M8.12M4.77M3.86M7.71M7.70M7.13M6.57M5.07M4.93M2.82M2.16M
EBITDA-70.99M-61.86M-71.64M-57.81M-147.32M-58.95M-106.44M-488.07M-76.72M-32.44M-11.54M34.18M-9.06M-11.05M-6.74M-7.23M3.05M20.97M1.31M-17.90M-27.76M-22.06M-12.57M-9.41M-6.87M-7.76M
EBITDA Margin-391.30%-158.54%-651.96%-836.07%-2,450.86%-999.20%-994.81%-32,538.27%-308.43%-216.29%-74.62%241.05%-55.55%-51.73%-48.88%-74.97%19.16%154.15%9.85%-147.12%-1,016.02%-434.95%-363.46%-532.44%-602.29%-632.58%
EBIT-72.39M-63.29M-73.39M-59.73M-164.27M-61.20M-108.44M-489.10M-77.31M-38.70M-12.15M33.72M-10.25M-12.51M-9.07M-8.34M-2.58M19.68M-7.67M-19.10M-34.56M-27.65M-16.34M-9.20M-8.17M-8.75M
EBIT Margin-399.04%-162.19%-667.91%-863.96%-2,732.84%-1,037.29%-1,013.45%-32,606.67%-310.80%-258.00%-78.59%237.77%-62.84%-58.61%-65.79%-86.54%-16.22%144.70%-57.72%-156.98%-1,264.97%-545.07%-472.38%-520.56%-716.68%-713.22%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙